Raymond James & Associates’s iShares iBonds Mar 2023 Term Corporate ETF IBDD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-55,815
Closed -$1.48M 4132
2022
Q4
$1.48M Buy
55,815
+1,664
+3% +$44K ﹤0.01% 2188
2022
Q3
$1.43M Buy
54,151
+3,911
+8% +$103K ﹤0.01% 2175
2022
Q2
$1.33M Buy
50,240
+42,111
+518% +$1.12M ﹤0.01% 2257
2022
Q1
$216K Hold
8,129
﹤0.01% 3629
2021
Q4
$218K Hold
8,129
﹤0.01% 3648
2021
Q3
$219K Hold
8,129
﹤0.01% 3619
2021
Q2
$220K Buy
+8,129
New +$220K ﹤0.01% 3630

Other funds holding IBDD

Raymond James & Associates's IBDD Position: Q1 2023 in Review

Raymond James & Associates sold out of iShares iBonds Mar 2023 Term Corporate ETF (IBDD) in Q1 2023, closing a stake of 55,815 shares — an estimated $1.48M sold.

Raymond James & Associates first reported a position in IBDD in Q2 2021 and held it in 7 quarters. The position peaked at $1.48M in Q4 2022. 5 funds tracked by Wall St. Rank hold IBDD as of Q1 2023.

  • Raymond James & Associates reported no remaining iShares iBonds Mar 2023 Term Corporate ETF position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 55,815 iShares iBonds Mar 2023 Term Corporate ETF shares in Q1 2023, an estimated $1.48M.
  • Raymond James & Associates first reported a position in iShares iBonds Mar 2023 Term Corporate ETF in Q2 2021 and held it in 7 quarters.
  • Raymond James & Associates's iShares iBonds Mar 2023 Term Corporate ETF position peaked at $1.48M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held iShares iBonds Mar 2023 Term Corporate ETF as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.